drugset / Trial / NCT01315002

Nicotine Effects on Endophenotypes of Schizophrenia

NCT01315002

RandomizedCrossoverDouble-blindBasic science

Summary

The purpose of this study is to test the effects of nicotine on cognition with the following schizophrenia endophenotypes: prepulse inhibition, antisaccades, the continuous performance test, spatial working memory and a verbal memory task. Schizophrenia patients, unaffected first-degree relatives of schizophrenia patients and healthy controls receive transdermal nicotine in a double-blind, placebo-controlled, crossover study.

Timeline

Start
2008-07
Primary completion
2012-03
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nicotine Unknown 7 mg Other
Comparator Nicotine Unknown 14 mg Other

Indications